Researchers controlled inflammation from multiple sclerosis in mice by programming immune cells to target glioblastoma. There will soon be a clinical trial to test the glioblastoma technique.
Brain Tumors
Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.